Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

365 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.
Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A; EXCITE Study Group. Schmidt-Erfurth U, et al. Among authors: guymer r. Ophthalmology. 2011 May;118(5):831-9. doi: 10.1016/j.ophtha.2010.09.004. Epub 2010 Dec 13. Ophthalmology. 2011. PMID: 21146229 Clinical Trial.
New treatments in age-related macular degeneration.
Hooper CY, Guymer RH. Hooper CY, et al. Clin Exp Ophthalmol. 2003 Oct;31(5):376-91. doi: 10.1046/j.1442-9071.2003.00683.x. Clin Exp Ophthalmol. 2003. PMID: 14516424 Review.
365 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page